Nav: Home

Scripps Florida scientist wins $2 million grant to study childhood disorder

May 31, 2017

JUPITER, FL - May 31, 2017 - Assistant Professor Seth Tomchik of the Florida campus of The Scripps Research Institute (TSRI) has received $2 million in funding from the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS). The new five-year grant funding will support the study of neurofibromatosis type I, an inherited disorder that results from genetic mutations affecting a protein called neurofibromin (Nf1).

There is currently no FDA-approved treatment for neurofibromatosis 1. The disease begins in childhood with symptoms ranging from harmless spots to nerve tumors. It also predisposes individuals to a suite of behavioral symptoms, including attention-deficit/hyperactivity disorder (ADHD), autism-like symptoms, learning disabilities and chronic pain. The prevalence of behavioral symptoms suggests that Nf1 can affect the development or function of neurons in the brain that regulate activity levels.

Because neurofibromin is a large protein with multiple potential signaling roles in cells, Tomchik's research will focus on the functions of Nf1 at several levels, examining its molecular biology, genetic interactions and effects on signaling and development of neuronal circuits.

"Aside from surgery to remove tumors, there are really no treatment options for those who suffer from neurofibromatosis," Tomchik said. "We intend to look at how the underlying protein regulates behavioral hyperactivity, determining how specific neuronal circuit alterations underlie its behavioral effects."
The grant number is 1R01NS097237.

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists--including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine--work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see

Scripps Research Institute

Related Neurofibromatosis Articles:

Scripps Florida scientist wins $2 million grant to study childhood disorder
Assistant Professor Seth Tomchik of the Florida campus of The Scripps Research Institute (TSRI) has received $2 million in funding from the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).
Could DNA from a virus millions of years old hold the key to new neuro tumor therapies?
Dr. Sylwia Ammoun, Senior Research Fellow at Plymouth University Peninsula Schools of Medicine and Dentistry, has received backing from children's charity Action Medical Research, to investigate new drug treatments for neurofibromatosis 2 -- and the secret may lie in sequences of DNA from viruses that are millions of years old.
Scripps Florida team illuminates molecular player in morphine addiction and rare disease
In a remarkable 'two for one' discovery, scientists from the Florida campus of The Scripps Research Institute (TSRI) have illuminated a key molecular player in the addictive effects of morphine in animal models.
Scripps Florida scientists show commonly prescribed painkiller slows cancer growth
Scientists from The Scripps Research Institute Florida campus have found that one of the most widely prescribed pain and anti-inflammation drugs slows the growth rate of a specific kind of cancer in animal models and suggests the medication could have the same effect on other types of tumors.
Stansfield honored by Southern Society for Pediatric Research
Dr. Brian K. Stansfield, neonatologist at Children's Hospital of Georgia and a 2004 graduate of the Medical College of Georgia at Augusta University, has received the 2016 Clinical Science Young Investigator Award from the Southern Society for Pediatric Research.
Anticancer drug restores hearing in some patients with neurofibromatosis
In a small clinical study with an anticancer drug that halts blood vessel growth, a handful of people with neurofibromatosis type 2 (NF2) and hearing loss had restoration of hearing.
60 genetic disorders affect skin and nervous system
At least 60 genetic diseases called neurocutaneous disorders involve the skin, central nervous system, and/or peripheral nervous system, Loyola University Medical Center neurologists report.
Researchers examine how neurofibromatosis causes premature cardiovascular disease
It's a fairly common genetic condition that can surface as a series of dark skin spots and result in a host of maladies from tumors to premature cardiovascular disease.
Better clinical management improves quality of life for neurofibromatosis patients
A genetic disorder called neurofibromatosis causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system.
A new mouse model for the study of neurofibromatosis
The research group of the neurofibromatosis of the Catalan Institute of Oncology, the Institute of Biomedical Research of Bellvitge and the Institute of Medicicina Predictive and Personalized Cancer has developed new mouse models for the study of principal malignant tumor associated with neurofibromatosis type 1.

Related Neurofibromatosis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".